Mason Carrico
Stock Analyst at Stephens
(0.39)
# 4,117
Out of 4,423 analysts
51
Total ratings
36%
Success rate
-8.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTKB Cytek Biosciences | Rated: Buy | $4 → $4.75 | $3.77 | +25.99% | 3 | May 13, 2026 | |
| ESTA Establishment Labs Holdings | Rated: Buy | $90 | $84.81 | +6.12% | 1 | Feb 25, 2026 | |
| GKOS Glaukos | Maintained: Buy | $115 → $145 | $130.68 | +10.96% | 2 | Jan 2, 2026 | |
| PACB Pacific Biosciences of California | Maintained: Buy | $2.5 → $2 | $1.40 | +42.86% | 3 | Nov 10, 2025 | |
| NEO NeoGenomics | Maintained: Buy | $18 → $11 | $11.13 | -1.17% | 4 | Sep 2, 2025 | |
| ILMN Illumina | Rated: Buy | $156 → $110 | $161.93 | -32.07% | 8 | Aug 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiated Coverage: Buy | $70 | $21.72 | +222.28% | 1 | Jul 9, 2025 | |
| MYGN Myriad Genetics | Reiterated: Hold | $24 → $30 | $4.54 | n/a | 5 | Oct 11, 2024 | |
| CDNA CareDx | Maintained: Buy | $15 → $18 | $26.18 | n/a | 7 | May 13, 2024 | |
| TXG 10x Genomics | Reiterated: Buy | $65 | $34.76 | n/a | 3 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $21.12 | n/a | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $63 | $131.78 | n/a | 3 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $231.41 | n/a | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $32 | $53.63 | n/a | 4 | Dec 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.1 → $1.25 | $5.44 | n/a | 2 | May 24, 2022 |
Cytek Biosciences
May 13, 2026
Rated: Buy
Price Target: $4 → $4.75
Current: $3.77
Upside: +25.99%
Establishment Labs Holdings
Feb 25, 2026
Rated: Buy
Price Target: $90
Current: $84.81
Upside: +6.12%
Glaukos
Jan 2, 2026
Maintained: Buy
Price Target: $115 → $145
Current: $130.68
Upside: +10.96%
Pacific Biosciences of California
Nov 10, 2025
Maintained: Buy
Price Target: $2.5 → $2
Current: $1.40
Upside: +42.86%
NeoGenomics
Sep 2, 2025
Maintained: Buy
Price Target: $18 → $11
Current: $11.13
Upside: -1.17%
Illumina
Aug 4, 2025
Rated: Buy
Price Target: $156 → $110
Current: $161.93
Upside: -32.07%
PROCEPT BioRobotics
Jul 9, 2025
Initiated Coverage: Buy
Price Target: $70
Current: $21.72
Upside: +222.28%
Myriad Genetics
Oct 11, 2024
Reiterated: Hold
Price Target: $24 → $30
Current: $4.54
Upside: n/a
CareDx
May 13, 2024
Maintained: Buy
Price Target: $15 → $18
Current: $26.18
Upside: n/a
10x Genomics
May 18, 2023
Reiterated: Buy
Price Target: $65
Current: $34.76
Upside: n/a
May 8, 2023
Reiterated: Buy
Price Target: $41
Current: $21.12
Upside: n/a
Feb 16, 2023
Reiterated: Buy
Price Target: $90 → $63
Current: $131.78
Upside: n/a
Dec 16, 2022
Maintained: Buy
Price Target: n/a
Current: $231.41
Upside: n/a
Dec 5, 2022
Reiterated: Buy
Price Target: $30 → $32
Current: $53.63
Upside: n/a
May 24, 2022
Downgraded: Hold
Price Target: $3.1 → $1.25
Current: $5.44
Upside: n/a